GAITHERSBURG, Md., Nov. 4, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its third quarter 2024 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Tuesday, November 12, 2024. Details of the event and replay are as follows:

Conference call details:

Date:

November 12, 2024

Time:

8:30 a.m. U.S. ET

URL to register phone:

https://emportal.ink/3Y6irHG

Dial-in number:

(800) 836-8184 (Domestic) or

(+1) (646) 357-8785 (International)

Webcast:

ir.novavax.com/events

As an Amazon Associate I earn from qualifying purchases.